By KLTV Newsdesk –

In a landmark victory following years of passionate campaigning by Caribbean and African community leaders, the UK government has announced a seismic shift in the fight against prostate cancer.

For the first time ever, every eligible Black man in the UK will be personally invited to take part in a major national screening trial.

Tens of thousands more black men aged 45 to 74 will be invited for prostate cancer screening as part of a major UK trial aimed at improving early detection of the disease.

The TRANSFORM trial, backed by over £20 million in new investment from the Health Secretary James Murray and supported by Prostate Cancer UK, is being radically expanded.

The government’s expansion of the trial has been welcomed by health charities, campaigners and medical experts, who say it could help address long-standing inequalities in cancer outcomes.

Prostate cancer is the most common cancer among men in the UK. While it affects men of all backgrounds, black men face a significantly higher risk.

In fact, research indicates they are around twice as likely to develop the disease as white men and are more likely to be diagnosed at a younger age.

According to PCR: ‘1 in 4 Black men will get prostate cancer. That’s double the risk of other men’

There is currently no national prostate cancer screening programme in the UK. Although PSA blood tests can help identify potential cases, they are not routinely offered to all men because of concerns over accuracy and the risk of unnecessary treatment.

Researchers hope the expanded trial will provide evidence on how prostate cancer can be detected earlier and more effectively among higher-risk groups.

Campaigners have described the move as a ‘historic step towards a more personalised approach to cancer prevention’.

Health experts stress that early diagnosis greatly improves treatment outcomes and long-term survival rates.

The findings from the trial could help shape future screening policies and potentially pave the way for more targeted approaches to prostate cancer testing for Britain’s black men by addressing the fact that the disease is equally as deadly for every other ethnicity.